5-fluorouracil promising for vaginal intraepithelial neoplasia

November 21, 2017

(HealthDay)—5-fluorouracil is associated with a 74 percent success rate as the initial treatment modality for high-grade intraepithelial vaginal dysplasia, according to a study published online Nov. 7 in Obstetrics & Gynecology.

Stephen Fiascone, M.D., from Brigham and Women's Hospital in Boston, and colleagues retrospectively reviewed the cases of women referred to a single center for management of high-grade vaginal intraepithelial neoplasia between April 1994 and May 2016 to assess the success rates of 5-fluorouracil, excision, and laser ablation as the initial and secondary management strategies.

The researchers found that 47 patients were treated initially with 5-fluorouracil, 35 were treated with excision, and 22 were treated with laser . The groups were similar demographically. There was no recurrence in 35 women treated with 5-fluorouracil (74 percent), 20 treated with excision (57 percent), or nine treated with (41 percent). Eight of the 13 patients treated with 5-fluorouracil for recurrence did not experience a second . Side effects were reported in nine of 58 (16 percent) ever treated with 5-fluorouracil, most commonly irritation and dyspareunia.

"The optimal treatment strategy for women with recurrent or persistent vaginal intraepithelial neoplasia is unclear from the current literature, and the data presented here show that topical 5-fluorouracil may have an important role in this context, especially given the morbidity associated with repeated vaginal surgeries," the authors write.

Explore further: Abnormal pap posthysterectomy for 30 percent of HIV+ women

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Abnormal pap posthysterectomy for 30 percent of HIV+ women

June 14, 2016
(HealthDay)—About one-in-three HIV-infected women with no prehysterectomy history of abnormal Pap results have abnormal vaginal Pap results after hysterectomy, according to a study published in the July issue of Obstetrics ...

Laser removal may be advantageous for treating precancerous skin lesions

November 21, 2011
Carbon dioxide laser ablation (removal) may have a role as an alternative treatment for a common precancerous skin lesion known as lentigo maligna when surgery or radiation therapy is not feasible, according to a report in ...

FDA approves new pancreatic cancer drug

October 22, 2015
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer.

Staged surgical excision superior for treatment of lentigo maligna

December 9, 2015
(HealthDay)—For patients with lentigo maligna, staged surgical excision is associated with a low rate of recurrence, according to research published online Nov. 30 in the British Journal of Dermatology.

Goal in stage Ia1 cervical cancer is complete excision

December 23, 2014
(HealthDay)—Clear excision margins are important in the management of stage Ia1 squamous cervical cancer, according to research published in the December issue of the American Journal of Obstetrics & Gynecology.

Endometrial ablation doesn't increase cancer risk

August 14, 2017
(HealthDay)—For women in Finland, endometrial ablation is not associated with increased risk of endometrial or breast cancer, according to a study published in the September issue of Obstetrics & Gynecology.

Recommended for you

Womb natural killer cell discovery could lead to screening for miscarriage risk

December 14, 2017
For the first time the functions of natural killer cells in the womb have been identified.

Hormone discovery marks breakthough in understanding fertility

December 12, 2017
Scientists at The University of Nottingham have shown, for the first time, that a naturally occurring hormone plays a vital part in regulating a woman's fertility, a discovery that could lead to better diagnosis and treatment ...

Study reveals Viagra to be 'ineffective' for fetal growth restriction

December 8, 2017
A University of Liverpool led international clinical trial has found an anti-impotence drug to be ineffective at improving outcomes for pregnancies complicated by fetal growth restriction.

Obese first-time mums more likely to have premature babies

December 4, 2017
Obese women are up to three times more likely to have a premature child during their first pregnancy, according to a study from University College Dublin.

Stillbirth is not just stillbirth—more information is needed

December 4, 2017
Forty two babies are stillborn in Australia every week, and 60 per cent of them are recorded as "unexplained".

First baby from a uterus transplant in the US born in Dallas

December 2, 2017
The first birth as a result of a womb transplant in the United States has occurred in Texas, a milestone for the U.S. but one achieved several years ago in Sweden.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.